Key Highlights
- Thyme Care secures strategic investments from Echo Health Ventures and CVS Health Ventures.
- Investment to fuel national expansion of Thyme Care’s value-based cancer care model.
- Kurt Sheline and Alyssa Reisner join as board observers.
- Thyme Care aims to transform cancer care with a patient-centered, provider-integrated approach.
Source: PR Newswire
Notable Quotes
- “We believe Thyme Care’s member-centric and provider-integrated approach is unique and has the potential to transform this status quo toward a value-based future that aligns incentives to improve outcomes and lower costs.” – Kurt Sheline, Partner at Echo Health Ventures
- “Thyme Care’s provider-driven approach is a powerful catalyst in enabling oncologists to navigate the shift to alternative payment models, fostering patient trust and elevating the role of the provider while driving significant cost savings throughout the care continuum.” – Alyssa Reisner, Partner at CVS Health Ventures
- “The investment from Echo and CVS is a milestone moment for Thyme Care driven by our commitment to working with partners dedicated to rethinking how we deliver and pay for cancer care.” – Brad Diephuis, MD, MBA, Chief Operations Officer and President at Thyme Care
SoHC's Take
Thyme Care’s recent investment from Echo Health Ventures and CVS Health Ventures marks a significant milestone in the evolution of value-based cancer care. By embedding their patient-centered resources within oncology practices and supporting oncologists with innovative payment models, Thyme Care addresses critical gaps in cancer care coordination and support. This approach not only aims to improve patient outcomes and satisfaction but also seeks to reduce healthcare costs—a dual benefit highly sought after in today’s healthcare landscape. The involvement of industry leaders like Echo and CVS underscores the confidence in Thyme Care’s model and its potential to reshape cancer care delivery on a national scale.
